NCT05889455View on ClinicalTrials.gov

Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

October 12, 2023

Study Completion Date

October 12, 2023

Conditions
Migraine Without Aura
Interventions
DRUG

Sildenafil

Oral administration of 100mg

OTHER

Placebo

Placebo

Trial Locations (1)

2600

Danish Headache Center, Copenhagen

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Danish Headache Center

OTHER